Sandra Aung
Chief Tech/Sci/R&D Officer chez AMBRX INC
Profil
Sandra Aung is currently the Chief Clinical Development Officer & Senior VP at OncoSec Medical, Inc. and the Chief Clinical Officer at Ambrx, Inc. She holds a doctorate degree from Vanderbilt University.
Postes actifs de Sandra Aung
Sociétés | Poste | Début |
---|---|---|
ONCOSEC MEDICAL INCORPORATED | Corporate Officer/Principal | 12/10/2020 |
AMBRX INC | Chief Tech/Sci/R&D Officer | 01/02/2023 |
Formation de Sandra Aung
Vanderbilt University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ONCOSEC MEDICAL INCORPORATED | Health Services |
Entreprise privées | 1 |
---|---|
Ambrx, Inc.
Ambrx, Inc. Pharmaceuticals: MajorHealth Technology Ambrx, Inc. engages in discovering and developing of protein therapeutics. It offers non-native amino acids through expanded genetic code to both generate novel bio-therapeutics. The company was founded by Richard DiMarchi, Peter G. Schultz, and Troy E. Wilson on April 15, 2003 and is headquartered in La Jolla, CA. | Health Technology |